Myeloid cell-specific lipin-1 deficiency stimulates endocrine adiponectin-FGF15 axis and ameliorates ethanol-induced liver injury in mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Jiayou ^a   Kim, Chunki ^a   Jogasuria, Alvin ^a   Han, Yoonhee ^a   Hu, Xudong ^a,b   Wu, Jiashin ^a   Shen, Hong ^a,c   Chrast, Roman ^d   Finck, Brian N ^e   You, Min ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^d KAROLINSKA INSTITUTE   (Sweden)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LPIN1 PROTEIN, MOUSE; NUCLEAR PROTEIN; PHOSPHATIDATE PHOSPHATASE;

ALCOHOLIC FATTY LIVER; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; BONE MARROW CELL; DEFICIENCY; DISEASE MODEL; GENE KNOCKOUT; GENETICS; LIPID METABOLISM; MALE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; DISEASE MODELS, ANIMAL; FATTY LIVER, ALCOHOLIC; FIBROBLAST GROWTH FACTORS; GENE KNOCKOUT TECHNIQUES; LIPID METABOLISM; MALE; MICE; MYELOID CELLS; NF-KAPPA B; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PHOSPHATIDATE PHOSPHATASE; SIGNAL TRANSDUCTION;

EID: 84988980807     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34117     Document Type: Article

References (35)

1. Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 141, 1572-1585, doi: 10.1053/j.gastro.2011.09.002 (2011).
2. Mandrekar, P., Bataller, R., Tsukamoto, H. & Gao, B. Alcoholic hepatitis: Translational approaches to develop targeted therapies. Hepatology. In press, doi: 10.1002/hep.28530 (2016).
3. Bou Khalil, M., Blais, A., Figeys, D. & Yao, Z. Lipin-The bridge between hepatic glycerolipid biosynthesis and lipoprotein metabolism. Biochim Biophys Acta. 1801, 1249-1259, doi: 10.1016/j.bbalip.2010.07.008 (2010).
4. Peterson, T. R., et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell. 146, 408-420, doi: 10.1016/j. cell.2011.06.034 (2011).
5. Finck, B. N., et al. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 4, 199-210, doi: 10.1016/j.cmet.2006.08.005 (2006).
6. Kim, H. B., et al. Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Mol Cell Biol. 30, 3126-3139, doi: 10.1128/MCB.01671-09 (2010).
7. Takahashi, N., et al. Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 415, 200-205, doi: 10.1016/j.bbrc.2011.10.060 (2011).
8. Lu, B., et al. LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab. 295, E1502-E1509, doi: 10.1152/ajpendo.90323.2008 (2008).
9. Hu, M., et al. Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice. Hepatology 58, 1953-1963, doi: 10.1002/hep.26589 (2013).
10. Yin, H., Liang, X., Jogasuria, A., Davidson, N. O. & You, M. miR-217 regulates ethanol-induced hepatic inflammation by disrupting sirtuin 1-lipin-1signaling. Am J Pathol. 185, 1286-1296, doi: 10.1016/j.ajpath.2015.01.030 (2015).
11. Navratil, A. R., et al. Lipin-1 contributes to modified low-density lipoprotein-elicited macrophage pro-inflammatory responses. Atherosclerosis 242, 424-432, doi: 10.1016/j.atherosclerosis.2015.08.012 (2015).
12. Meana, C., et al. Lipin-1 integrates lipid synthesis with proinflammatory responses during TLR activation in macrophages. J Immunol. 193, 4614-4622, doi: 10.4049/jimmunol.1400238 (2014).
13. Valdearcos, M., et al. Subcellular localization and role of lipin-1 in human macrophages. J Immunol. 186, 6004-6013, doi: 10.4049/jimmunol.1003279 (2011).
14. Yin, H., et al. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver. Gastroenterology 146, 801-811, doi: 10.1053/j.gastro.2013.11.008 (2014).
15. Everitt, H., et al. Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice. Am J Physiol Gastrointest Liver Physiol. 304, G38-G47, doi: 10.1152/ajpgi.00309.2012 (2013).
16. Hu, M., et al. Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase/sterol regulatory element-binding protein 1 signaling in mice. Hepatology 55, 437-446, doi: 10.1002/hep.24708 (2012).
17. Shen, Z., Liang, X., Rogers, C. Q., Rideout D. & You M. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol. 298, G364-G374, doi: 10.1152/ajpgi.00456.2009 (2010).
18. Simpson, K. J., Venkatesan, S., Martin, A., Brindley, D. N. & Peters, T. J. Activity and subcellular distribution of phosphatidate phosphohydrolase (EC 3. 134) in alcoholic liver disease. Alcohol Alcohol 30, 31-36 (1995).
19. Nadra, K., et al. Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes Dev. 22, 1647-1661, doi: 10.1101/gad.1638008 (2008).
20. Bertola, A., Mathews, S., Ki, S. H., Wang, H. & Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc. 8, 627-637, doi: 10.1038/nprot.2013.032 (2013).
21. Wieser, V., et al. Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease. J Hepatol. 64, 872-880, doi: 10.1016/j. jhep.2015.11.037 (2016).
22. Cohen, J. I., Roychowdhury, S., McMullen, M. R., Stavitsky, A. B. & Nagy, L. E. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139, 664-674, doi: 10.1053/j.gastro.2010.04.041 (2010).
23. You, M., Considine, R. V., Leone, T. C., Kelly, D. P. & Crabb, D. W. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology. 42, 568-577, doi: 10.1002/hep.20821 (2005).
24. Kusminski, C. M., et al. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med. 18, 1539-1549, doi: 10.1038/nm.2899 (2012).
25. Inagaki, T., et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217-225, doi: 10.1016/j.cmet.2005.09.001 (2005).
26. Ge, H., et al. Fibroblast growth factor receptor 4 (FGFR4) deficiency improves insulin resistance and glucose metabolism under dietinduced obesity conditions. J Biol Chem. 289, 30470-30480, doi: 10.1074/jbc.M114.592022 (2014).
27. Vergnes, L., Lee, J. M., Chin, R. G., Auwerx, J. & Reue, K. Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels. Cell Metab. 17, 916-928, doi: 10.1016/j.cmet.2013.04.007 (2013).
28. Bechmann, L. P., et al. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectincounteracts bile acidinduced liver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology. 57, 1394-1406, doi: 10.1002/hep.26225 (2013).
29. Claudel, T. & Trauner, M. Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradox. Hepatology 57, 2106-2109, doi: 10.1002/hep.26340 (2013).
30. Park, P. H., Sanz-Garcia, C. & Nagy L. E. Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Curr Pathobiol Rep. 3, 243-252, doi: 10.1007/s40139-015-0094-y (2015).
31. Zhou, M., et al. Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice. Hepatology 63, 914-929, doi: 10.1002/hep.28257 (2016).
32. Hall, A., et al. Lipopolysaccharide induces a downregulation of adiponectin receptors in-vitro and in-vivo. PeerJ. 3, e1428, doi: 10.7717/peerj.1428 (2015).
33. Liang, X., et al. Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice. Antioxid Redox Signal 15, 425-435, doi: 10.1089/ars.2010.3780 (2011).
34. Yan, C., et al. The Detrimental Role Played by Lipocalin-2 in Alcoholic Fatty Liver in Mice. Am J Pathol. 186, 2417-2428, doi: 10.1016/j.ajpath.2016.05.006 (2016).
35. Simpson, K. J., et al. Activity and subcellular distribution of phosphatidate phosphohydrolase (EC 3. 134) in alcoholic liver disease. Alcohol Alcohol 30, 31-36 (1995).